Verified email-pattern data for Cadrenal Therapeutics, Inc. (Nasdaq: Cvkd) is currently limited. You can still use the company insights and contact sections below.
Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, an oral therapeutic designed to be a superior and safer Vitamin K antagonist (VKA) anticoagulant for patients with implanted cardiac devices or rare cardiovascular (CV) conditions. Cadrenal strives to improve outcomes and reduce adverse events for these patients such as strokes, heart attacks, bleeds, and deaths. These patients also lack approved chronic anticoagulation options besides warfarin, well-known for its serious side effects and frequent drug-drug interactions, resulting in complicated treatment management.
Cadrenal’s drug candidate, tecarfarin, is a new VKA anticoagulant with extensive clinical data showing it is potentially superior and safer than warfarin, resulting in fewer adverse events. Tecarfarin is metabolized via a different pathway than warfarin and data demonstrate that its efficacy is unaffected by common drug-drug interactions or kidney impairment, which are common in these patients. Phase 2/3 clinical trials show that tecarfarin may offer more stability and time in therapeutic range (TTR) that inversely correlates with major events.
Tecarfarin received an orphan drug designation for advanced heart failure patients with left ventricular assist devices (LVADs) as well as both orphan drug and fast-track status for end-stage kidney disease (ESKD) patients with atrial fibrillation. Cadrenal is opportunistically pursuing pivotal clinical trials with LVAD patients along with clinical and commercial partnership opportunities to advance tecarfarin. The company’s plans also include studying patients with mechanical heart valves who experience anticoagulation difficulties because of genetic warfarin resistance, polypharmacy, or kidney impairment.
For more information, please visit: www.cadrenal.com.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 822 A1a N, Ponte Vedra,florida 32082,united States
- Industry
- Biotechnology Research
- Website
- https://www.cadrenal.com
- Keywords
- Cardiovascular, Renal failure, Kidney diseases, Atrial fibrillation, Orphan, Rare disease, Mechanical heart valve, Dialysis.
- HQ
- Ponte Vedra, Florida
Cadrenal Therapeutics, Inc. (Nasdaq: Cvkd) Questions
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s website is https://www.cadrenal.com
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s LinkedIn profile is https://www.linkedin.com/company/cadrenal
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) has
6 employees.
View email and phone details for 6
employees at Cadrenal Therapeutics, Inc. (Nasdaq: CVKD).
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s industry is
Biotechnology Research
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s top competitors are
Zura Bio Limited (Nasdaq: Zura),
Apogee Therapeutics,
Structure Therapeutics,
60 Degrees Pharmaceuticals, Inc,
Genelux,
Adiso Therapeutics,
Acelyrin, Inc.,
Mineralys Therapeutics, Inc.,
Mira Pharmaceuticals,
Cytomed Therapeutics Limited.
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s categories are Biotechnology Research
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s founding year is 2022
Explore related pages
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) company profile
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) management contacts
Related company profiles:
Companies like Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
Top Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) Employees
-
Quang X. Pham
Chairman And Ceo, Cadrenal Therapeutics (Nasdaq: Cvkd) | Director | Bestselling Author | Speaker | Marine Corps Veteran/Aviator
Metro Jacksonville, United States, United States3lathian.com, wamsystems.com, esperobio.com1 +194937XXXXX
-
John Murphy
Board Of Directors: O'Reilly Auto (Nasdaq:Orly), Cadrenal Therapeutics (Nasdaq: Cvkd). Former Ceo/Cfo Public Co'S
Ponte Vedra Beach, Florida, United States, United States5aol.com, gmail.com, alightinc.com, summit-materials.com, djoglobal.com4 +151653XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.